drugset / Trial / NCT02249936
A Phase 1 Study to Examine the Pharmacodynamics of Different AZD1722 Formulations
RandomizedCrossoverQuadruple-blindTreatment
Summary
The study is designed to evaluate safety, tolerability, pharmacodynamics and pharmacokinetics of different formulations of AZD1722 in healthy male and female subjects taking Omeprazole.
Timeline
- Start
- 2013-02
- Primary completion
- 2013-02
- Completion
- 2013-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tenapanor | Small molecule | 15 mg | — |
| Background | Omeprazole | Other / unclassified | 20 mg | — |
Indications
No indication recorded.